Ibogaine's safety profile is pretty good, there is a reason it is legal in other countries. The cardiac risk factors can be mitigated with appropriate screening, and of course, it should not be consumed with other substances with unsafe drug interactions. To the extent that Ibogaine fatalities have occurred, they are largely attributable to these two factors. In this respect, it is not especially different from plenty of other OTC and prescription drugs.
This is not to say that Ibogaine has zero risk for either physical or psychological harm---this cannot be said about very many perscription drugs either. However, given its efficacy for treating opiod use disorders alone, along with its safety profile, there is no logical reason that it should be out of reach for mental health professionals, let alone a schedule 1 substance.
Honestly, if Altman stays gone and they burn the motherfucker down it might be a good lesson for Silicon Valley on the wisdom of throwing out founders.
I don't expect it to happen, but a boy can dream.
They would be studying that one in business schools for the next century.
This is not to say that Ibogaine has zero risk for either physical or psychological harm---this cannot be said about very many perscription drugs either. However, given its efficacy for treating opiod use disorders alone, along with its safety profile, there is no logical reason that it should be out of reach for mental health professionals, let alone a schedule 1 substance.